-
1
-
-
33846457870
-
Cancer statistics, 2007
-
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-46
-
(2007)
CA Cancer J Clin
, vol.57
, pp. 43-46
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Murray, T.4
Xu, J.5
Thun, M.J.6
-
2
-
-
0016957980
-
The vascularization of tumors
-
Folkman J: The vascularization of tumors. Sci Am 1976;234: 58-64, 70-73
-
(1976)
Sci Am
, vol.234
, Issue.58-64
, pp. 70-73
-
-
Folkman, J.1
-
3
-
-
0030866894
-
Vascular density is a predictor of cancer-specific survival in prostatic carcinoma
-
DOI 10.1002/(SICI)1097-0045(19970915)33:1<38::AID-PROS7>3.0.CO;2-5
-
Lissbrant IF, Stattin P, Damber JE, Bergh A: Vascular density is a predictor of cancer-specific survival in prostatic carcinoma. Prostate 1997;33:38-45 (Pubitemid 27381593)
-
(1997)
Prostate
, vol.33
, Issue.1
, pp. 38-45
-
-
Lissbrant, I.F.1
Stattin, P.2
Damber, J.-E.3
Bergh, A.4
-
4
-
-
0033844219
-
Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients
-
Mazzucchelli R, Montironi R, Santinelli A, Lucarini G, Pugnaloni A, Biagini G: Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients. Prostate 2000;45:72-79
-
(2000)
Prostate
, vol.45
, pp. 72-79
-
-
Mazzucchelli, R.1
Montironi, R.2
Santinelli, A.3
Lucarini, G.4
Pugnaloni, A.5
Biagini, G.6
-
5
-
-
0038577078
-
The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer
-
Kikuno N, Yoshino T, Urakami S, Shigeno K, Kishi H, Hata K, Shiina H, Igawa M: The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer. Anticancer Res 2003;23:1305-1312 (Pubitemid 36754092)
-
(2003)
Anticancer Research
, vol.23
, Issue.2 B
, pp. 1305-1312
-
-
Kikuno, N.1
Yoshino, T.2
Urakami, S.3
Shigeno, K.4
Kishi, H.5
Hata, K.6
Shiina, H.7
Igawa, M.8
-
6
-
-
17544397076
-
Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer
-
DOI 10.1002/(SICI)1097-0045(20000101)42:1<26::AID-PROS4>3.0.CO;2-6
-
Strohmeyer D, Rössing C, Strauss F, Bauerfeind A, Kaufmann O, Loening S: Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer. Prostate 2000;42:26-33 (Pubitemid 30004872)
-
(2000)
Prostate
, vol.42
, Issue.1
, pp. 26-33
-
-
Strohmeyer, D.1
Rossing, C.2
Strauss, F.3
Bauerfeind, A.4
Kaufmann, O.5
Loening, S.6
-
7
-
-
33746161915
-
Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues
-
Pallares J, Rojo F, Iriarte J, Morote J, Armadans LI, de Torres I: Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues. Histol Histopathol 2006;21:857-865 (Pubitemid 44082728)
-
(2006)
Histology and Histopathology
, vol.21
, Issue.7-9
, pp. 857-865
-
-
Pallares, J.1
Rojo, F.2
Iriarte, J.3
Morote, J.4
Armadans, L.I.5
De Torres, I.6
-
8
-
-
27644582050
-
Angiogeneses with pericyte abnormalities in a transgenic model of prostate carcinoma
-
DOI 10.1002/cncr.21436
-
Ozawa MG, Yao VJ, Chanthery YH, Troncoso P, Uemura A, Varner AS, Kasman IM, Pasqualini R, Arap W, McDonald DM: Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma. Cancer 2005;104:2104-2115 (Pubitemid 41579956)
-
(2005)
Cancer
, vol.104
, Issue.10
, pp. 2104-2115
-
-
Ozawa, M.G.1
Yao, V.J.2
Chanthery, Y.H.3
Troncoso, P.4
Uemura, A.5
Varner, A.S.6
Kasman, I.M.7
Pasqualini, R.8
Arap, W.9
McDonald, D.M.10
-
9
-
-
0028911462
-
Prostate cancer in a transgenic mouse
-
Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM: Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A 1995;92:3439-3443
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, pp. 3439-3443
-
-
Greenberg, N.M.1
DeMayo, F.2
Finegold, M.J.3
Medina, D.4
Tilley, W.D.5
Aspinall, J.O.6
Cunha, G.R.7
Donjacour, A.A.8
Matusik, R.J.9
Rosen, J.M.10
-
10
-
-
0038415024
-
Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model
-
DOI 10.1002/pros.10215
-
Kaplan-Lefko PJ, Chen TM, Ittmann MM, Barrios RJ, Ayala GE, Huss WJ, Maddison LA, Foster BA, Greenberg NM: Pathobiology of autochthonous prostate cancer in a preclinical transgenic mouse model. Prostate 2003;55:219-237 (Pubitemid 36532401)
-
(2003)
Prostate
, vol.55
, Issue.3
, pp. 219-237
-
-
Kaplan-Lefko, P.J.1
Chen, T.-M.2
Ittmann, M.M.3
Barrios, R.J.4
Ayala, G.E.5
Huss, W.J.6
Maddison, L.A.7
Foster, B.A.8
Greenberg, N.M.9
-
11
-
-
36048989332
-
Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model
-
DOI 10.1593/neo.07562
-
Huss WJ, Gray DR, Tavakoli K, Marmillion ME, Durham LE, Johnson MA, Greenberg NM, Smith GJ: Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model. Neoplasia 2007;9: 938-950 (Pubitemid 350086439)
-
(2007)
Neoplasia
, vol.9
, Issue.11
, pp. 938-950
-
-
Huss, W.J.1
Gray, D.R.2
Tavakoli, K.3
Marmillion, M.E.4
Durham, L.E.5
Johnson, M.A.6
Greenberg, N.M.7
Smith, G.J.8
-
12
-
-
56249085576
-
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent, poorly differentiated carcinoma in TRAMP mice
-
Bono AV, Montironi R, Pannellini T, Sasso F, Mirone V, Musiani P, Iezzi M: Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent, poorly differentiated carcinoma in TRAMP mice. Prostate Cancer Prostatic Dis 2008;11:377-383
-
(2008)
Prostate Cancer Prostatic Dis
, vol.11
, pp. 377-383
-
-
Bono, A.V.1
Montironi, R.2
Pannellini, T.3
Sasso, F.4
Mirone, V.5
Musiani, P.6
Iezzi, M.7
-
13
-
-
0042807497
-
Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies
-
Martiniello-Wilks R, Dane A, Mortensen E, Jeyakumar G, Wang XY, Russell PJ: Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies. Anticancer Res 2003;23:2633-2642 (Pubitemid 36897137)
-
(2003)
Anticancer Research
, vol.23
, Issue.3 B
, pp. 2633-2642
-
-
Martiniello-Wilks, R.1
Dane, A.2
Mortensen, E.3
Jeyakumar, G.4
Wang, X.Y.5
Russell, P.J.6
-
14
-
-
0036401105
-
BAY 43-9006: Preclinical data
-
Wilhelm S, Chien DS: BAY 43-9006: Preclinical data. Curr Pharm Des 2002;8:2255-2257
-
(2002)
Curr Pharm des
, vol.8
, pp. 2255-2257
-
-
Wilhelm, S.1
Chien, D.S.2
-
15
-
-
4944249117
-
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/ MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
-
Wilhelm SM, Carter C, Tang L, Wilkie D, McNabola A, Rong H, Chen C, Zhang X, Vincent P, McHugh M, Cao Y, Shujath J, Gawlak S, Eveleigh D, Rowley B, Liu L, Adnane L, Lynch M, Auclair D, Taylor I, Gedrich R, Voznesensky A, Riedl B, Post LE, Bollag G, Trail PA: BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/ MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res 2004;64: 7099-7109
-
(2004)
Cancer Res
, vol.64
, pp. 7099-7109
-
-
Wilhelm, S.M.1
Carter, C.2
Tang, L.3
Wilkie, D.4
McNabola, A.5
Rong, H.6
Chen, C.7
Zhang, X.8
Vincent, P.9
McHugh, M.10
Cao, Y.11
Shujath, J.12
Gawlak, S.13
Eveleigh, D.14
Rowley, B.15
Liu, L.16
Adnane, L.17
Lynch, M.18
Auclair, D.19
Taylor, I.20
Gedrich, R.21
Voznesensky, A.22
Riedl, B.23
Post, L.E.24
Bollag, G.25
Trail, P.A.26
more..
-
16
-
-
36448965291
-
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: A study of the CESAR Central European Society for Anticancer Drug Research-EWIV
-
DOI 10.1038/sj.bjc.6604064, PII 6604064
-
Steinbild S, Mross K, Frost A, Morant R, Gillessen S, Dittrich C, Strumberg D, Hochhaus A, Hanauske AR, Edler L, Burkholder I, Scheulen M: A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: A study of the CESAR Central European Society for Anticancer Drug Research-EWIV. Br J Cancer 2007;97: 1480-1485 (Pubitemid 350175850)
-
(2007)
British Journal of Cancer
, vol.97
, Issue.11
, pp. 1480-1485
-
-
Steinbild, S.1
Mross, K.2
Frost, A.3
Morant, R.4
Gillessen, S.5
Dittrich, C.6
Strumberg, D.7
Hochhaus, A.8
Hanauske, A.-R.9
Edler, L.10
Burkholder, I.11
Scheulen, M.12
-
17
-
-
0033556011
-
Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12
-
Cavallo F, Di Carlo E, Butera M, Verrua R, Colombo MP, Musiani P, Forni G: Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12. Cancer Res 1999;59:414-421 (Pubitemid 29048877)
-
(1999)
Cancer Research
, vol.59
, Issue.2
, pp. 414-421
-
-
Cavallo, F.1
Di Carlo, E.2
Butera, M.3
Verrua, R.4
Colombo, M.P.5
Musiani, P.6
Forni, G.7
-
18
-
-
33847337912
-
Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+ CD25+ T regulatory cells: Role of tumor-derived TGF-beta
-
Liu VC, Wong LY, Jang T, Shah AH, Park I, Yang X, Zhang Q, Lonning S, Teicher BA, Lee C: Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+ CD25+ T regulatory cells: Role of tumor-derived TGF-beta. J Immunol 2007;178:2883-2892
-
(2007)
J Immunol
, vol.178
, pp. 2883-2892
-
-
Liu, V.C.1
Wong, L.Y.2
Jang, T.3
Shah, A.H.4
Park, I.5
Yang, X.6
Zhang, Q.7
Lonning, S.8
Teicher, B.A.9
Lee, C.10
-
19
-
-
33846646456
-
The effects of aging on tumor growth and angiogenesis are tumor-cell dependent
-
DOI 10.1002/ijc.22351
-
Reed MJ, Karres N, Eyman D, Cruz A, Brekken RA, Plymate S: The effects of aging on tumor growth and angiogenesis are tumor-cell dependent. Int J Cancer 2007;120:753-760 (Pubitemid 46175393)
-
(2007)
International Journal of Cancer
, vol.120
, Issue.4
, pp. 753-760
-
-
Reed, M.J.1
Karres, N.2
Eyman, D.3
Cruz, A.4
Brekken, R.A.5
Plymate, S.6
-
20
-
-
0035866779
-
Angiogenesis and prostate cancer: Identification of a molecular progression switch
-
Huss WJ, Hanrahan CF, Barrios RJ, Simons JW, Greenberg NM: Angiogenesis and prostate cancer: Identification of a molecular progression switch. Cancer Res 2001;61:2736-2743 (Pubitemid 32685863)
-
(2001)
Cancer Research
, vol.61
, Issue.6
, pp. 2736-2743
-
-
Huss, W.J.1
Hanrahan, C.F.2
Barrios, R.J.3
Simons, J.W.4
Greenberg, N.M.5
-
21
-
-
0034941823
-
Autochthonous mouse models for prostate cancer: Past, present and future
-
Huss WJ, Maddison LA, Greenberg NM: Autochthonous mouse models for prostate cancer: Past, present and future. Semin Cancer Biol 2001;11:245-260
-
(2001)
Semin Cancer Biol
, vol.11
, pp. 245-260
-
-
Huss, W.J.1
Maddison, L.A.2
Greenberg, N.M.3
-
22
-
-
33749441325
-
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
-
DOI 10.1172/JCI24612
-
Mancuso MR, Davis R, Norberg SM, O'Brien S, Sennino B, Nakahara T, Yao VJ, Inai T, Brooks P, Freimark B, Shalinsky DR, Hu-Lowe DD, McDonald DM: Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest 2006;116:2610-2621 (Pubitemid 44511625)
-
(2006)
Journal of Clinical Investigation
, vol.116
, Issue.10
, pp. 2610-2621
-
-
Mancuso, M.R.1
Davis, R.2
Norberg, S.M.3
O'Brien, S.4
Sennino, B.5
Nakahara, T.6
Yao, V.J.7
Inai, T.8
Brooks, P.9
Freimark, B.10
Shalinsky, D.R.11
Hu-Lowe, D.D.12
McDonald, D.M.13
-
23
-
-
0040143484
-
Angiogenesis in the bovine corpus luteum: An immunocytochemical and ultrastructural study
-
Amselgruber WM, Schäfer M, Sinowatz F: Angiogenesis in the bovine corpus luteum: An immunocytochemical and ultrastructural study. Anat Histol Embryol 1999;28:157-166 (Pubitemid 129503255)
-
(1999)
Anatomia, Histologia, Embryologia
, vol.28
, Issue.3
, pp. 157-166
-
-
Amselgruber, W.M.1
Schafer, M.2
Sinowatz, F.3
-
24
-
-
0032768156
-
Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse
-
Hellström M, Kalén M, Lindahl P, Abramsson A, Betsholtz C: Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999; 126:3047-3055 (Pubitemid 29378170)
-
(1999)
Development
, vol.126
, Issue.14
, pp. 3047-3055
-
-
Hellstrom, M.1
Kalen, M.2
Lindahl, P.3
Abramsson, A.4
Betsholtz, C.5
-
25
-
-
0035670380
-
TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells
-
Darland DC, D'Amore PA: TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis 2001; 4:11-20
-
(2001)
Angiogenesis
, vol.4
, pp. 11-20
-
-
Darland, D.C.1
D'Amore, P.A.2
-
26
-
-
0032544686
-
Tumor induction of VEGF promoter activity in stromal cells
-
DOI 10.1016/S0092-8674(00)81731-6
-
Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK, Seed B: Tumor induction of VEGF promoter activity in stromal cells. Cell 1998; 94:715-725 (Pubitemid 28436004)
-
(1998)
Cell
, vol.94
, Issue.6
, pp. 715-725
-
-
Fukumura, D.1
Xavier, R.2
Sugiura, T.3
Chen, Y.4
Park, E.-C.5
Lu, N.6
Selig, M.7
Nielsen, G.8
Taksir, T.9
Jain, R.K.10
Seed, B.11
-
27
-
-
0035347301
-
Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival
-
Reinmuth N, Liu W, Jung YD, Ahmad SA, Shaheen RM, Fan F, Bucana CD, McMahon G, Gallick GE, Ellis LM: Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J 2001;15: 1239-1241
-
(2001)
FASEB J
, vol.15
, pp. 1239-1241
-
-
Reinmuth, N.1
Liu, W.2
Jung, Y.D.3
Ahmad, S.A.4
Shaheen, R.M.5
Fan, F.6
Bucana, C.D.7
McMahon, G.8
Gallick, G.E.9
Ellis, L.M.10
-
28
-
-
0042125242
-
Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall
-
DOI 10.1101/gad.266803
-
Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellstrom M, Backstrom G, Fredriksson S, Landegren U, Nystrom HC, Bergstrom G, Dejana E, Ostman A, Lindahl P, Betsholtz C: Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 2003;17:1835-1840 (Pubitemid 36944561)
-
(2003)
Genes and Development
, vol.17
, Issue.15
, pp. 1835-1840
-
-
Lindblom, P.1
Gerhardt, H.2
Liebner, S.3
Abramsson, A.4
Enge, M.5
Hellstrom, M.6
Backstrom, G.7
Fredriksson, S.8
Landegren, U.9
Nystrom, H.C.10
Bergstrom, G.11
Dejana, E.12
Ostman, A.13
Lindahl, P.14
Betsholtz, C.15
|